A systematic review of 112 studies looked at how Astragalus membranaceus, a traditional herb, and its derivatives affect digestive system diseases, autoimmune conditions, and tumors. The review focused on the herb's ability to modulate the immune system.
The findings suggest that Astragalus membranaceus and its derivatives can help restore immune tolerance and rebalance key immune pathways, such as Th1/Th2 and Treg/Th17. This may help reinstate immune homeostasis, which is important for managing digestive diseases.
However, the review did not provide specific clinical trial data or individual study results. It also did not report on safety, adverse events, or how the herb compares to standard treatments. The evidence is based on a collection of studies, not a single large trial.
While these results are promising, they are not yet practice-changing. The review offers a theoretical basis for developing new drugs from Astragalus membranaceus, but more research is needed before it can be recommended for treatment. Readers should consult their doctor before using any herbal supplement.
